|Day Low/High||2,550.00 / 2,600.00|
|52 Wk Low/High||2,020.00 / 2,614.00|
Monsanto shares should rise if the $129-per-share deal, including a massive break fee, is confirmed, while Bayer investors appear unsure whether to celebrate or mourn.
Futures point toward a higher open Wednesday after strong drops Tuesday amid rate jitters and lower oil.
Bayer is upping its bid for Monsanto (MON), this time to $129 per share, according to Bloomberg.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: NILE, NL, UGP, YUME Downgrades: AIRT, ASM, BFS, ETP, FNV, GCAP, JNP, MON, TEDU Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
Monsanto's (MON) board could decide on the proposed acquisition by Bayer (BAYRY) today, sources told Reuters.
A deal between Bayer (BAYRY) and Monsanto (MON) could be announced next week, BloombergTV reports.
Bayer increases its latest offer to buy Monsanto, as regulators look closely at agribusiness mergers.
Bayer increases its latest offering to entice Monsanto, as regulators look closely at agribusiness mergers.
Antitrust issues are substantial but could be overcome.
Investors continue to see good news in weaker economic indicators, which may dissuade the Fed from raising rates quickly.
Weaker chances of a rate hike when the Federal Reserve meets in two weeks left Wall Street in a bright mood on its return from the long Labor Day weekend.
Bayer (BAYRY) said it was still in advanced discussions to acquire Monsanto (MON) for up to $127.50 per share.
These names show the downward pull can be beaten with the right set of circumstances, and it happens more often than you might think.
Stocks hold slight gains through to mid-afternoon Tuesday after weaker U.S. services activity pushes back the chances of a September interest rate hike.
A sweeter deal from Bayer doesn't mean a merger for Monsanto is near, says Jim Cramer.
Monsanto Company (NYSE: MON) and Second Genome, Inc. have announced a research agreement to accelerate the discovery of new microbiome-based solutions to help farmers better manage environmental challenges on their farms.
Stocks hold mixed by mid-morning Tuesday after U.S. services activity last month declines more than expected.
Shares in the German chemicals maker fall on confirmation of an improved $65 billion bid for the world's biggest seedmaker, while Monsanto rises in the pre-market.
Stock futures edge higher in the return from the long Labor Day weekend as markets continue to mull over the Federal Reserve's next big move.
Navistar shares were rallying Tuesday on news of a major stake taken by Volkswagen.
Monsanto (MON) stock is increasing in early-morning trading on Tuesday as Bayer said it was still in advanced negotiations to acquire the company for up to $127.50 per share.
Bayer has sweetened its offer to buy Monsanto.
GE acquires two 3D printing companies in Europe for $1.4 billion; Bayer raises its bid again for Monsanto; Volkswagen reportedly plans to buy a minority stake in Navistar International.
Payment systems maker Ingenico plunges in Paris after cutting its full-year forecast but British homebuilders take heart from updates from Berkeley and Redrow.
Monsanto Company (NYSE:MON) confirmed it has been engaged in constructive negotiations with Bayer AG, during which it has received an updated non-binding proposal for a potential acquisition of Monsanto for $127.
Monsanto previously rejected a bid of $125 per share, which Bayer said it could increase to up to $127.50 per share.
Reports suggest Bayer's board will meet next week to ponder if it should take its Monsanto bid straight to shareholders. Monsanto investors should hope that's true.
Even if the Dow merger with DuPont fails, Dow is in good shape.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.